Stefan Leucht
Impact in
- Psychiatry and Mental health top 0.01%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Biological Psychiatry top 0.02%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 337
- Bipolar Disorder and Treatment 91
- Pharmacology 102
- Treatment of Major Depression 99
- Co-authors
- Werner Kissling (93 shared papers)John M. Davis (76 shared papers)Rolf R. Engel (37 shared papers)John M. Kane (30 shared papers)Georgia Salanti (54 shared papers)Stephan Heres (36 shared papers)Myrto Samara (51 shared papers)Andrea Cipriani (47 shared papers)
- Journals
- Cochrane Database of Systematic Reviews (58 papers)Schizophrenia Research (37 papers)Schizophrenia Bulletin (35 papers)European Neuropsychopharmacology (29 papers)The Lancet Psychiatry (18 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Stefan Leucht
448 papers receiving 33.9k citations
Stefan Leucht's Hit Papers
Peers
Comparison fields: 5 of 203
- Psychiatry and Mental health 22.2k
- Biological Psychiatry 3.5k
- Philosophy 5.0k
- Pharmacology 5.7k
- Clinical Psychology 6.7k
Countries citing papers authored by Stefan Leucht
This map shows the geographic impact of Stefan Leucht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Leucht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Leucht more than expected).
Fields of papers citing papers by Stefan Leucht
This network shows the impact of papers produced by Stefan Leucht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Leucht. The network helps show where Stefan Leucht may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Leucht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 485 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis Hit paper breakdown → | 2018 | 2064 |
| 2 | Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis Hit paper breakdown → | 2013 | 1824 |
| 3 | Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care Hit paper breakdown → | 2011 | 1705 |
| 4 | Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Hit paper breakdown → | 2008 | 1403 |
| 5 | Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis Hit paper breakdown → | 2019 | 963 |
| 6 | Clinical implications of Brief Psychiatric Rating Scale scores Hit paper breakdown → | 2005 | 683 |
| 7 | Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level Hit paper breakdown → | 2011 | 623 |
| 8 | Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials Hit paper breakdown → | 1999 | 619 |
| 9 | Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis Hit paper breakdown → | 2012 | 594 |
| 10 | Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis Hit paper breakdown → | 2010 | 513 |
| 11 | Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1. Hit paper breakdown → | 2016 | 485 |
| 12 | Physical illness and schizophrenia: a review of the literature Hit paper breakdown → | 2007 | 483 |
| 13 | 2004 | 481 | |
| 14 | Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis Hit paper breakdown → | 2016 | 464 |
| 15 | 2003 | 387 | |
| 16 | 2008 | 361 | |
| 17 | Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors Hit paper breakdown → | 2017 | 350 |
| 18 | 2008 | 349 | |
| 19 | 2003 | 330 | |
| 20 | 2011 | 319 |
About Stefan Leucht
Stefan Leucht is a scholar working on Psychiatry and Mental health, Pharmacology, Philosophy, Clinical Psychology and Experimental and Cognitive Psychology, having authored 485 papers that have together received 34.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (337 papers), Mental Health and Psychiatry (101 papers), Treatment of Major Depression (99 papers), Bipolar Disorder and Treatment (91 papers), Mental Health Research Topics (71 papers), Health Systems, Economic Evaluations, Quality of Life (63 papers), Obsessive-Compulsive Spectrum Disorders (38 papers) and Functional Brain Connectivity Studies (36 papers). The work is most often cited by research in Psychiatry and Mental health (22.2k citations), Biological Psychiatry (3.5k citations), Philosophy (5.0k citations), Pharmacology (5.7k citations) and Clinical Psychology (6.7k citations). Stefan Leucht has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Werner Kissling, John M. Davis, Rolf R. Engel, John M. Kane, Georgia Salanti, Stephan Heres, Myrto Samara, Andrea Cipriani, Christoph U. Correll and Johannes Hamann. Their work appears in journals such as Cochrane Database of Systematic Reviews, Schizophrenia Research, Schizophrenia Bulletin, European Neuropsychopharmacology and The Lancet Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.